from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3536c/hsaE

LFCtreatmentdescriptionclass of inhibitor

-0.115

Amikacinug/mL Amikacintranslation

-0.170

Cap5-10ug/mL Capreomycintranslation

0.751

Rox10-50 ug/mL Roxithromycintranslation

-0.298

SM2-5 ug/mL Streptomycintranslation

0.701

Tet5-10 ug/mL Tetracyclinetranslation

0.464

Rif0.2-5ug/mL Rifampicintranscription

-0.989

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.047

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.415

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.657

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.031

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.416

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.875

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.286

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.153

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.849

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.288

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.448

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.843

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.008

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.564

KCN5-20 ug/mL Potassium cyaniderespiration

-0.604

NaN30.2-2 mM Sodium aziderespiration

0.203

Nigericin50 uM Nigericinrespiration

0.750

TRC10-150 ug/mL Triclosanrespiration

-0.012

TRZ10-25 ug/mL Thioridazinerespiration

3.213

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.977

menadione6-10 ug/mL Menadionerespiration

1.374

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.327

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.275

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.408

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.243

NRP_1Non-replicating persistence stage 1dosRassociated

-0.433

Amp0.2mg/mL AmpicillincellWall

-0.748

Cephalexin20-100 ug/mL CephalexincellWall

-0.551

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.621

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.409

EMB10-20 ug/mL EthambutolcellWall

-0.411

Eta12-40 ug/mL EthionamidecellWall

-0.556

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.015

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.391

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.870

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.215

BZA0.12 mg/mL BenzamidearomaticAmides

-0.139

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.030

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.501

H2O24 mM hydrogen peroxideDNAdamaging

-0.516

Levo10 ug/mL LevofloxacinDNAdamaging

-0.281

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.630

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.200

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.345

UVUV-irradiationDNAdamaging

1.325

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.229

Antimycin12.5-50 ug/mL Antimycin A?

-0.474

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.112

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.426

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.549

PA8240.2-2 ug/mL PA-824?

1.314

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.287

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.014

Verapamil50 uM Verapamil?

-0.801

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.466

methoxatin10-20 ug/mL Methoxatin?